<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sumida</surname>
    <given-names>S. M.</given-names>
   </name>
   <name>
    <surname>Truitt</surname>
    <given-names>D. M.</given-names>
   </name>
   <name>
    <surname>Lemckert</surname>
    <given-names>A. A.</given-names>
   </name>
   <name>
    <surname>Vogels</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Custers</surname>
    <given-names>J. H.</given-names>
   </name>
   <name>
    <surname>Addo</surname>
    <given-names>M. M.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2005</year>). 
  <article-title>Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein</article-title>. 
  <source>J. Immunol.</source>
  <volume>174</volume>, 
  <fpage>7179</fpage>â€“
  <lpage>7185</lpage>. 
  <pub-id pub-id-type="doi">10.4049/jimmunol.174.11.7179</pub-id>
  <?supplied-pmid 15905562?>
  <pub-id pub-id-type="pmid">15905562</pub-id>
 </mixed-citation>
</ref>
